US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

      Summary Company Announcement Date: March 29, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Drug Recalls / Risperdal / Highest Court in PA Set to Consider Tolling Statute of Limitations in Risperdal Cases

Highest Court in PA Set to Consider Tolling Statute of Limitations in Risperdal Cases

November 12, 2018 By Lynn Fugaro Leave a Comment

Judge Reviewing Case

In July 2018, the Pennsylvania Supreme Court announced its decision to review a ruling by the Pennsylvania Court of Common Pleas regarding the statute of limitations in a case regarding the drug Risperdal. Essentially, the Supreme Court will have to decide whether the Court of Common Pleas was correct in dismissing the Plaintiffs’ case on summary judgment, ruling that the statute of limitations barred the plaintiffs from any recovery.

Background

In 2015, Jonathan Saksek and Joshua Winter’s consolidated cases against Janssen Pharmaceuticals were dismissed by the Pennsylvania Court of Common Pleas. Both plaintiffs alleged that Janssen’s drug Risperdal caused them to develop female breast tissue, a condition known as gynecomastia. The Court of Common Pleas did not dismiss the case because there was no proof that Risperdal causes the condition, but because the statute of limitations had run its course. In Pennsylvania, there is a two-year statute of limitations on tort cases.

Judge New, the coordinating judge for Philadelphia’s mass tort program in the Court of Common Pleas, ruled that since Janssen had changed the drug’s label in 2006, both plaintiffs should have been aware at that time of the connection between Risperdal and gynecomastia and they then had two years to file their case. Because they didn’t file until 2014, their cases could not go forward.

Judge New also wrote in his ruling that if the change of the drug’s label wasn’t enough, articles, medical literature, and advertisements should have made the Plaintiffs aware in 2009, and thus their claims should have been filed no later than 2011.

The Superior Court ruled: “Their breasts were there, and had been there, for years. And then, in October 2006, the label on Risperdal changed, expressly linking usage of the drug to gynecomastia.” It went on to say “…by that date, reasonable minds would not differ in finding that appellants knew, or should have known…the cause of those injuries by this point.”

The lawyers for Saksek and Winter alleged that even though both Plaintiffs’ breast tissue growth started back in 1998 and 2002, both plaintiffs were going through puberty at the time, which made it very difficult to attribute the growth to Risperdal instead of just to typical weight gain during puberty.

Tolling

Even though the Superior Court affirmed Judge New’s ruling, Saksek and Winter appealed to the Supreme Court. In July, the Supreme Court agreed to review the case, and Thomas Kline and Chip Becker, the attorneys for the Plaintiffs, filed their first brief to the Supreme Court last week.  Kline and Becker are asking the Supreme Court to toll the statute of limitations.

Plaintiffs want the Supreme Court to rule that the statute of limitations can be delayed in this case because the Plaintiffs were not aware that the drug caused their condition until much later than asserted in the Court of Common Pleas’ ruling.

Plaintiffs argue that even though it has been more than two years since they developed symptoms, they should be able to file their lawsuit after that period since they lacked the knowledge necessary in 2009 or 2011 to file their case within the time limit required by the statute of limitations.

The Supreme Court’s decision will not only affect Jonathan Saksek and Joshua Winter’s case, but the nearly 3,000 other cases pending against Janssen Pharmaceuticals alleging Risperdal caused their gynecomastia.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Drug Recalls, Risperdal

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

March 29, 2023 By The FDA

North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce

March 27, 2023 By The FDA

Gilster-Mary Lee Corp. Issues a Recall for Undeclared Milk Allergen in HyVee Hamburger Chili Macaroni Skillet Meal

March 27, 2023 By The FDA

Free Case Review

  • * = Required
    Privacy Policy
  • This field is for validation purposes and should be left unchanged.

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards

March 22, 2023 By The CPSC

Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)

March 22, 2023 By The CPSC

Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
(Recall Alert)

March 22, 2023 By The CPSC

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

March 21, 2023 By The FDA

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

March 21, 2023 By The FDA

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces

March 20, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites
  • North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce
  • Gilster-Mary Lee Corp. Issues a Recall for Undeclared Milk Allergen in HyVee Hamburger Chili Macaroni Skillet Meal
  • Jarman’s Midwest Cleaning Systems, Inc. Issues Voluntary Nationwide Recall of Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution and Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Non-sterile Solution Due to Presence of Methanol
  • Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle
  • Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards
  • Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)
  • Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
    Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
    (Recall Alert)
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in